Teva Pharm to stay as unified generics, branded drugmaker -CEO says
In this article:
TEL AVIV, Feb 20 (Reuters) - Teva Pharmaceutical Industries will remain a single company for both generic and branded drugs since generics help to fund research and development of its innovative medicines, chief executive Richard Francis said on Tuesday.
Speaking at a news conference, Francis also said Teva expects significant interest in its active pharmaceutical ingredients (API) business that it plans to divest.
(Reporting by Steven Scheer; Editing by Kirsten Donovan)
